129 related articles for article (PubMed ID: 23217280)
1. Polysaccharide-K (PSK) increases p21(WAF/Cip1) and promotes apoptosis in pancreatic cancer cells.
Rosendahl AH; Sun C; Wu D; Andersson R
Pancreatology; 2012; 12(6):467-74. PubMed ID: 23217280
[TBL] [Abstract][Full Text] [Related]
2. Polysaccharide krestin is a novel TLR2 agonist that mediates inhibition of tumor growth via stimulation of CD8 T cells and NK cells.
Lu H; Yang Y; Gad E; Wenner CA; Chang A; Larson ER; Dang Y; Martzen M; Standish LJ; Disis ML
Clin Cancer Res; 2011 Jan; 17(1):67-76. PubMed ID: 21068144
[TBL] [Abstract][Full Text] [Related]
3. pERK1/2 silencing sensitizes pancreatic cancer BXPC-3 cell to gemcitabine-induced apoptosis via regulating Bax and Bcl-2 expression.
Wang M; Lu X; Dong X; Hao F; Liu Z; Ni G; Chen D
World J Surg Oncol; 2015 Feb; 13():66. PubMed ID: 25880226
[TBL] [Abstract][Full Text] [Related]
4. Induction of growth inhibition and apoptosis in pancreatic cancer cells by auristatin-PE and gemcitabine.
Li Y; Singh B; Ali N; Sarkar FH
Int J Mol Med; 1999 Jun; 3(6):647-53. PubMed ID: 10341297
[TBL] [Abstract][Full Text] [Related]
5. Reactivation of p53 by novel MDM2 inhibitors: implications for pancreatic cancer therapy.
Azmi AS; Philip PA; Aboukameel A; Wang Z; Banerjee S; Zafar SF; Goustin AS; Almhanna K; Yang D; Sarkar FH; Mohammad RM
Curr Cancer Drug Targets; 2010 May; 10(3):319-31. PubMed ID: 20370686
[TBL] [Abstract][Full Text] [Related]
6. Antitumor effects of all-trans retinoic acid and its synergism with gemcitabine are associated with downregulation of p21-activated kinases in pancreatic cancer.
Wang K; Baldwin GS; Nikfarjam M; He H
Am J Physiol Gastrointest Liver Physiol; 2019 May; 316(5):G632-G640. PubMed ID: 30844294
[TBL] [Abstract][Full Text] [Related]
7. Cucurbitacin B induces apoptosis by inhibition of the JAK/STAT pathway and potentiates antiproliferative effects of gemcitabine on pancreatic cancer cells.
Thoennissen NH; Iwanski GB; Doan NB; Okamoto R; Lin P; Abbassi S; Song JH; Yin D; Toh M; Xie WD; Said JW; Koeffler HP
Cancer Res; 2009 Jul; 69(14):5876-84. PubMed ID: 19605406
[TBL] [Abstract][Full Text] [Related]
8. Berbamine enhances the antineoplastic activity of gemcitabine in pancreatic cancer cells by activating transforming growth factor-β/Smad signaling.
Jin X; Wu Y
Anat Rec (Hoboken); 2014 May; 297(5):802-9. PubMed ID: 24619961
[TBL] [Abstract][Full Text] [Related]
9. Inhibiting signal transducer and activator of transcription-3 increases response to gemcitabine and delays progression of pancreatic cancer.
Venkatasubbarao K; Peterson L; Zhao S; Hill P; Cao L; Zhou Q; Nawrocki ST; Freeman JW
Mol Cancer; 2013 Sep; 12(1):104. PubMed ID: 24025152
[TBL] [Abstract][Full Text] [Related]
10. Dihydroartemisinin inhibits growth of pancreatic cancer cells in vitro and in vivo.
Chen H; Sun B; Pan S; Jiang H; Sun X
Anticancer Drugs; 2009 Feb; 20(2):131-40. PubMed ID: 19209030
[TBL] [Abstract][Full Text] [Related]
11. Antisense inhibition of microRNA-21 or -221 arrests cell cycle, induces apoptosis, and sensitizes the effects of gemcitabine in pancreatic adenocarcinoma.
Park JK; Lee EJ; Esau C; Schmittgen TD
Pancreas; 2009 Oct; 38(7):e190-9. PubMed ID: 19730150
[TBL] [Abstract][Full Text] [Related]
12. Interleukin 35 Expression Correlates With Microvessel Density in Pancreatic Ductal Adenocarcinoma, Recruits Monocytes, and Promotes Growth and Angiogenesis of Xenograft Tumors in Mice.
Huang C; Li Z; Li N; Li Y; Chang A; Zhao T; Wang X; Wang H; Gao S; Yang S; Hao J; Ren H
Gastroenterology; 2018 Feb; 154(3):675-688. PubMed ID: 28989066
[TBL] [Abstract][Full Text] [Related]
13. Contrasting roles of H3K4me3 and H3K9me3 in regulation of apoptosis and gemcitabine resistance in human pancreatic cancer cells.
Lu C; Yang D; Sabbatini ME; Colby AH; Grinstaff MW; Oberlies NH; Pearce C; Liu K
BMC Cancer; 2018 Feb; 18(1):149. PubMed ID: 29409480
[TBL] [Abstract][Full Text] [Related]
14. Interplay Between Gemcitabine and Erlotinib Over Pancreatic Adenocarcinoma Cells.
Torres C; Linares A; Alejandre MJ; Palomino-Morales RJ; Delgado JR; Perales S
Pancreas; 2016 Feb; 45(2):269-80. PubMed ID: 26495790
[TBL] [Abstract][Full Text] [Related]
15. Honokiol arrests cell cycle, induces apoptosis, and potentiates the cytotoxic effect of gemcitabine in human pancreatic cancer cells.
Arora S; Bhardwaj A; Srivastava SK; Singh S; McClellan S; Wang B; Singh AP
PLoS One; 2011; 6(6):e21573. PubMed ID: 21720559
[TBL] [Abstract][Full Text] [Related]
16. The synergism of Clinacanthus nutans Lindau extracts with gemcitabine: downregulation of anti-apoptotic markers in squamous pancreatic ductal adenocarcinoma.
Hii LW; Lim SE; Leong CO; Chin SY; Tan NP; Lai KS; Mai CW
BMC Complement Altern Med; 2019 Sep; 19(1):257. PubMed ID: 31521140
[TBL] [Abstract][Full Text] [Related]
17. BRG1 promotes chemoresistance of pancreatic cancer cells through crosstalking with Akt signalling.
Liu X; Tian X; Wang F; Ma Y; Kornmann M; Yang Y
Eur J Cancer; 2014 Sep; 50(13):2251-62. PubMed ID: 24953335
[TBL] [Abstract][Full Text] [Related]
18. PSK induces apoptosis through the inhibition of activated STAT3 in human esophageal carcinoma cells.
Umehara S; Fujiwara H; Shiozaki A; Todo M; Furutani A; Yoneda M; Ikai A; Tada H; Komatsu S; Ichikawa D; Okamoto K; Ochiai T; Kokuba Y; Otsuji E
Int J Oncol; 2012 Jul; 41(1):61-6. PubMed ID: 22552778
[TBL] [Abstract][Full Text] [Related]
19. Polysaccharide-K (PSK) in cancer--old story, new possibilities?
Sun C; Rosendahl AH; Wang XD; Wu DQ; Andersson R
Curr Med Chem; 2012; 19(5):757-62. PubMed ID: 22204346
[TBL] [Abstract][Full Text] [Related]
20. TLR2 agonist PSK activates human NK cells and enhances the antitumor effect of HER2-targeted monoclonal antibody therapy.
Lu H; Yang Y; Gad E; Inatsuka C; Wenner CA; Disis ML; Standish LJ
Clin Cancer Res; 2011 Nov; 17(21):6742-53. PubMed ID: 21918170
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
